Uncertain Future For Orphazyme After Arimoclomol Snub In Europe

European Medicines Agency Likely To Advise Rejection Of Arimoclomol For Niemann-Picks Type C

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".